| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $3.87 | - | - |
| Q1'26 | $3.76 | $3.79 | +0.9% |
| Q4'25 | $3.92 | $4.04 | +3.1% |
| Q3'25 | $3.40 | $3.68 | +8.3% |
| Q2'25 | $3.43 | $3.86 | +12.5% |
| Q1'25 | $2.81 | $3.79 | +35.0% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $3.2B | - | - |
| Q1'26 | $3.0B | $3.1B | +1.8% |
| Q4'25 | $3.1B | $3.5B | +11.0% |
| Q3'25 | - | $3.2B | - |
| Q2'25 | - | $3.1B | - |
| Q1'25 | - | $2.7B | - |
Market Data
HII is currently trading at $317.22, giving Huntington Ingalls Industries, Inc. a market cap of 12.63B and a P/E ratio of 20.9. Today's range spans $317.20–$326.99, with shares opening at $320.35 and moving down $3.41 (1.1%) from the prior close. DailyIQ's technical score sits at 27/100 (SELL) with a news sentiment reading of 49/100.
Over the past year HII has traded between $215.05 and $460.00 - the current price is +47.5% off the 52-week low and -31.0% from the high.
The path of least resistance for Huntington Ingalls Industries, Inc. (HII) is currently lower - 27/100 (SELL), neutral sentiment (49/100), price $317.22 (in the lower half of its 52-week range within $215.05–$460.00). The current P/E ratio stands at 20.9. At 12.63B in Industrials market cap, this large-cap name is in the zone where portfolio risk managers - not just traders - are making decisions. Trimming positions on technical deterioration is standard practice at this size, and the current setup gives them a clear rationale to act.
Analyst coverage for HII becomes a double-edged factor in a SELL phase: at 12.63B in Industrials market cap, active coverage is high enough that downgrade risk is real and impactful. The 27/100 technical reading and neutral sentiment (49/100) at $317.22 (in the lower half of its 52-week range) place the stock in the zone where one or two high-profile estimate cuts can convert a grinding decline into a sharper re-rating — the $215.05–$460.00 range establishes where that repricing lands.
Most recent articles, ranked by recency (click to expand).
Sentiment gathered from recent headlines